A combination of preoperative or intraoperative MB-PDT and surgery in the treatment of giant cutaneous squamous cell carcinoma with infection

医学 光动力疗法 伤口愈合 抗生素 放射治疗 病态的 外科 病理 生物 微生物学 有机化学 化学
作者
Luming Xu,Xinying Li,Chuanqi Zhao,Xincun Zhang,Huiling Kou,Yunchuan Yang,Fengjun Zhu,Wanqi Zhang,Yuangang Lu
出处
期刊:Photodiagnosis and Photodynamic Therapy [Elsevier]
卷期号:36: 102545-102545 被引量:2
标识
DOI:10.1016/j.pdpdt.2021.102545
摘要

Giant cutaneous squamous cell carcinoma (cSCC) with infection is a major clinical issue, as the infection not only promotes the progress of tumor, but also effects the success of surgery. Traditional antibiotic treatment is not always sufficient to clear the infection, especially for cSCC infected with multidrug-resistant bacteria. Photodynamic therapy (PDT) has broad-spectral antibacterial activity and non-selective pressure, which makes it difficult to induce antibiotic resistance. Here, we aim to evaluate the safety and efficacy of PDT, along with photosensitizers MB (Methylene blue) - in the treatment of cSCC infected with multidrug-resistant bacteria.In our study, 6 patients with giant csCC accompanied infection were diagnosed by pathological examination and the depth of tumor tissues was examined by X-Ray or MRI. All patients' tumor wounds were firstly irradiated with MB-PDT (635 nm, 120 J/cm2, 100 mW/cm2) using the red LED to control the infection. After the control of infection was confirmed by the culture of secretion, tumor underwent expanded resection. Multi-point pathological monitoring was performed during the operation to assure that there was no residual tumor tissue on the wound, and the primary or secondary repair was performed according to the condition of the wound. If the wound requires the tissue flaps transplation in secondary stage, the wound was irradiated again with intraoperative MB-PDT to remove the possible residual tumor cells, as well as to prevent wound infection. All patients were followed up for 0.8-3 years after flap transplation.In 6 patients, the cSCC infection was completely controlled by MB-PDT, and the flap survival was 100%. There was no recurrence of cSCC in the follow-up of 1.6 years (range, 0.8-3 years) after the comminated treatment with MB-PDT and surgery.Multi-drug resistant bacteria could efficiently be killed by MB-PDT, and the combination of surgery with MB-PDT is a safe and effective approach for treating giant cSCC with infection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱民发布了新的文献求助10
1秒前
511完成签到 ,获得积分10
1秒前
Zeger116完成签到,获得积分10
1秒前
bono完成签到 ,获得积分10
2秒前
前野风完成签到,获得积分10
3秒前
6秒前
6秒前
zgsslq完成签到,获得积分10
7秒前
ding完成签到,获得积分10
8秒前
yiqifan完成签到,获得积分10
8秒前
不想搞事完成签到 ,获得积分10
8秒前
呱呱呱发布了新的文献求助10
10秒前
11秒前
jyhk完成签到,获得积分10
12秒前
xiaolv发布了新的文献求助10
12秒前
情怀应助DraGon采纳,获得10
14秒前
刘亦菲完成签到,获得积分10
16秒前
17秒前
77要减肥完成签到 ,获得积分10
17秒前
恐龙植树发布了新的文献求助10
17秒前
呱呱呱完成签到,获得积分10
17秒前
18秒前
没有你不行完成签到,获得积分10
19秒前
无花果应助刘亦菲采纳,获得10
21秒前
LienAo完成签到 ,获得积分10
21秒前
Accepted完成签到,获得积分10
22秒前
情怀应助爱民采纳,获得10
22秒前
23秒前
甜甜玫瑰完成签到,获得积分10
24秒前
勤恳的宛菡完成签到,获得积分10
29秒前
清脆的霸完成签到 ,获得积分20
29秒前
scq完成签到 ,获得积分10
29秒前
无语的如音完成签到,获得积分10
30秒前
俭朴大开完成签到,获得积分10
30秒前
DAWN完成签到 ,获得积分10
31秒前
阿浮完成签到 ,获得积分10
35秒前
爱民完成签到,获得积分10
40秒前
40秒前
cyril完成签到 ,获得积分10
42秒前
44秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
A radiographic standard of reference for the growing knee 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2469017
求助须知:如何正确求助?哪些是违规求助? 2136228
关于积分的说明 5442990
捐赠科研通 1860861
什么是DOI,文献DOI怎么找? 925477
版权声明 562694
科研通“疑难数据库(出版商)”最低求助积分说明 495093